Michael Lane - 03 Aug 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role: Executive Vice President
Signature: /s/ Lily J. Lu, Attorney-in-Fact for Michael Lane
Issuer symbol: IDXX
Transactions as of: 03 Aug 2023
Net transactions value: -$5,169,172
Form type: 4
Filing time: 07 Aug 2023, 17:04:57 UTC
Previous filing: 08 May 2023
Next filing: 08 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IDXX	Common Stock	Options Exercise	$214,099	+1,512	+37%	$141.60	5,546	03 Aug 2023	Direct	F1
transaction	IDXX	Common Stock	Options Exercise	$1,325,363	+7,435	+134%	$178.26	12,981	03 Aug 2023	Direct
transaction	IDXX	Common Stock	Options Exercise	$1,465,135	+7,080	+55%	$206.94	20,061	03 Aug 2023	Direct
transaction	IDXX	Common Stock	Sale	$8,173,770	-16,027	-80%	$510.00	4,034	03 Aug 2023	Direct	F2
holding	IDXX	Common Stock						592	03 Aug 2023	by spouse	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IDXX	Incentive Stock Option (right-to-buy)	Options Exercise	$0	-1,512	-100%	$0.000000^*	0	03 Aug 2023	Common Stock	1,512	$141.60	Direct	F4
transaction	IDXX	Incentive Stock Option (right-to-buy)	Options Exercise	$0	-7,435	-100%	$0.000000^*	0	03 Aug 2023	Common Stock	7,435	$178.26	Direct	F5
transaction	IDXX	Incentive Stock Option (right-to-buy)	Options Exercise	$0	-7,080	-85%	$0.000000	1,286	03 Aug 2023	Common Stock	7,080	$206.94	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2023.
F2	Represents the weighted average price of the shares sold ranging from a low of $510.00 to a high of $510.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3	Held by spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
F4	Grant of option to buy 10,386 shares of Issuer common stock that vested in five annual installments beginning February 14, 2018.
F5	Grant of option to buy 9,434 shares of Issuer common stock that vested in five annual installments beginning February 14, 2019.
F6	Grant of option to buy 8,366 shares of Issuer common stock that vested in five annual installments beginning February 14, 2020.